Skip to main content
logo
BioVaxys Technology Corp. (CSE:BIOV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0700
+0.0100 (16.67%)
May 5, 2026, 3:55 PM EST

BioVaxys Technology Ratios and Metrics

Millions CAD. Fiscal year is Nov - Oct.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '26 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20
Market Capitalization
3184223430
Market Cap Growth
-64.94%395.74%-83.41%-34.60%14.06%-
Enterprise Value
3184223330
Last Close Price
0.070.700.252.053.704.20

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '26 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20
PB Ratio
-0.85-9.55-1.10-28.844.173.13
P/TBV Ratio
----43.7413.83

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '26 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20
Debt / Equity Ratio
-0.04-0.04----
Net Debt / Equity Ratio
-0.040.0800.18-0.07-0.25
Quick Ratio
0.100.200.030.111.962.75
Current Ratio
0.280.400.030.442.683.40
Return on Equity (ROE)
----316.82%-72.82%-22.62%
Return on Assets (ROA)
-152.79%-275.96%-306.75%-50.74%-39.41%-11.72%
Return on Capital Employed (ROCE)
127.40%162.60%71.30%491.60%-73.10%-10.60%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '26 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20
Earnings Yield
-193.41%-21.56%-207.75%-52.57%-18.93%-3.93%
Buyback Yield / Dilution
-61.26%-45.90%-36.63%-18.39%-193.97%-171.65%